Published in Amino Acids on September 17, 2013
A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair. PLoS One (2015) 0.87
Lysine nutrition in swine and the related monogastric animals: muscle protein biosynthesis and beyond. Springerplus (2015) 0.81
Simultaneous detection of lysine metabolites by a single LC-MS/MS method: monitoring lysine degradation in mouse plasma. Springerplus (2016) 0.75
Biochemical Principles and Functional Aspects of Pipecolic Acid Biosynthesis in Plant Immunity. Plant Physiol (2017) 0.75
Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats. Front Neurol (2016) 0.75
Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder. Mol Neuropsychiatry (2016) 0.75
Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism. Neurotherapeutics (2016) 0.75
Biochemical pathways supporting beta-lactam biosynthesis in the springtail Folsomia candida. Biol Open (2016) 0.75
Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism. Mol Neurobiol (2016) 0.75
Anaplerotic therapy in propionic acidemia. Mol Genet Metab (2017) 0.75
Comprehensive metabolic characterization of serum osteocalcin action in a large non-diabetic sample. PLoS One (2017) 0.75
The availability of the acetyl derivatives of lysine for growth. Biochem J (1943) 11.78
NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res (2000) 4.66
The conversion of tryptophan to kynurenine in liver. II. The enzymatic hydrolysis of formylkynurenine. J Biol Chem (1950) 3.56
Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry (2010) 2.46
Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev (1993) 2.45
D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry (1998) 2.36
Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med (2006) 2.28
Increased cortical kynurenate content in schizophrenia. Biol Psychiatry (2001) 2.27
Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics (1954) 2.17
Oxy radicals, lipid peroxidation and DNA damage. Toxicology (2002) 1.98
Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry (2003) 1.93
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett (2001) 1.89
Ontogeny of the human central nervous system: what is happening when? Early Hum Dev (2005) 1.85
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Familial hyperlysinemia with lysine-ketoglutarate reductase insufficiency. J Clin Invest (1969) 1.65
Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol (2006) 1.65
DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol (2005) 1.63
Conversion of lysine to saccharopine by human tissues. Biochim Biophys Acta (1968) 1.58
The conversion of lysine to pipecolic acid in the rat. J Biol Chem (1954) 1.56
Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones. J Neurochem (2011) 1.54
Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene (2006) 1.50
Saccharopinuria: a new inborn error of lysine metabolism. Nature (1968) 1.45
Saccharopine, a product of lysine breakdown by mammalian liver. Biochem Biophys Res Commun (1965) 1.43
Fits, pyridoxine, and hyperprolinaemia type II. Arch Dis Child (2000) 1.42
Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am J Hum Genet (2002) 1.39
Relationship of c-erbA mRNA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J Biol Chem (1990) 1.38
Enzymatic synthesis of L-pipecolic acid and L-proline. J Biol Chem (1957) 1.36
L-Lysine:alpha-ketoglutarate aminotransferase. I. Identification of a product, delta-1-piperideine-6-carboxylic acid. Biochemistry (1968) 1.35
Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol Neurobiol (2011) 1.33
High dose D-serine in the treatment of schizophrenia. Schizophr Res (2010) 1.33
Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress. J Biol Chem (2010) 1.28
Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat (2007) 1.26
The role of iodine in brain development. Proc Nutr Soc (2000) 1.25
Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood (2007) 1.23
Isolation and properties of highly purified glutamine transaminase. Biochemistry (1972) 1.22
D-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes. Brain Res (1994) 1.20
Lysine metabolism in mammals. Biochem J (1973) 1.20
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res (2008) 1.20
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci (2009) 1.19
Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein. Mol Endocrinol (1997) 1.18
Human aldehyde dehydrogenase 3A1 inhibits proliferation and promotes survival of human corneal epithelial cells. J Biol Chem (2005) 1.17
Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry (2005) 1.17
Seasonal differences of gene expression profiles in song sparrow (Melospiza melodia) hypothalamus in relation to territorial aggression. PLoS One (2009) 1.16
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem (2007) 1.15
L-Pipecolic acid oxidase, a human enzyme essential for the degradation of L-pipecolic acid, is most similar to the monomeric sarcosine oxidases. Biochem J (2000) 1.15
Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status. J Biol Chem (2008) 1.15
Metabolism of pipecolic acid in a Pseudomonas species. 3. L-alpha-aminoadipate delta-semialdehyde:nicotinamide adenine dinucleotide oxidoreductase. J Biol Chem (1966) 1.11
Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain (2010) 1.11
D-amino acids as putative neurotransmitters: focus on D-serine. Neurochem Res (2000) 1.10
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res (2008) 1.08
Dimethylarginine:pyruvate aminotransferase in rats. Purification, properties, and identity with alanine:glyoxylate aminotransferase 2. J Biol Chem (1990) 1.08
Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr Neuropharmacol (2006) 1.07
Metabolism of lysine in rat liver. Biochem Biophys Res Commun (1967) 1.07
The metabolism of D- and L-lysine in the intact rat, perfused liver and liver mitochondria. Biochim Biophys Acta (1968) 1.06
The pcd gene encoding piperideine-6-carboxylate dehydrogenase involved in biosynthesis of alpha-aminoadipic acid is located in the cephamycin cluster of Streptomyces clavuligerus. J Bacteriol (1998) 1.06
Development of excitatory synapses in cultured neurons dissociated from the cortices of rat embryos and rat pups at birth. J Neurosci Res (2002) 1.05
The glutamate analogue alpha-aminoadipic acid is taken up by astrocytes before exerting its gliotoxic effect in vitro. J Neurosci (1984) 1.05
Metabolism of lysine in alpha-aminoadipic semialdehyde dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic acid formation. FEBS Lett (2010) 1.03
A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model. Neurotox Res (2009) 1.03
Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells. Cancer Prev Res (Phila) (2009) 1.01
Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney. J Biol Chem (1995) 1.01
L-alpha-aminoadipate inhibits kynurenate synthesis in rat brain hippocampus and tissue culture. Neurochem Res (1997) 1.01
Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources. Biochem Biophys Res Commun (1973) 1.01
Seasonal and regional differences in gene expression in the brain of a hibernating mammal. PLoS One (2013) 1.00
Metabolism of pipecolic acid in a Pseudomonas species. V. Pipecolate oxidase and dehydrogenase. J Bacteriol (1967) 0.99
The conversion of L-lysine to saccharopine and alpha-aminoadipate in mouse. Arch Biochem Biophys (1971) 0.99
Identification of estrogen-responsive genes in the parenchyma and fat pad of the bovine mammary gland by microarray analysis. Physiol Genomics (2006) 0.99
Lysine degradation through the saccharopine pathway in mammals: involvement of both bifunctional and monofunctional lysine-degrading enzymes in mouse. Biochem J (1999) 0.99
The kynurenine transaminase of rat kidney. J Biol Chem (1954) 0.99
Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Biosci Rep (2008) 0.99
Alpha-Aminoadipate aminotransferase and kynurenine aminotransferase. Purification, characterization, and further evidence for identity. J Biol Chem (1977) 0.99
Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. Adv Clin Chem (2008) 0.98
Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol Cell Biol (2008) 0.98
Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res (2007) 0.98
Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells. FEBS Lett (1987) 0.98
Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures. J Neurosci (2010) 0.98
Developmental changes of L-lysine-ketoglutarate reductase in rat brain and liver. Comp Biochem Physiol B (1992) 0.98
Characterization of the human homolog of the IL-4 induced gene-1 (Fig1). Biochim Biophys Acta (2002) 0.97
Two roles for mu-crystallin: a lens structural protein in diurnal marsupials and a possible enzyme in mammalian retinas. Mol Vis (1997) 0.96
Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy. Exp Neurol (2007) 0.96
Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia. Am J Hum Genet (2000) 0.96
Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene (2006) 0.95
The transamination of kynurenine. J Biol Chem (1953) 0.95
IL-4-induced gene-1 is a leukocyte L-amino acid oxidase with an unusual acidic pH preference and lysosomal localization. J Immunol (2004) 0.95
Pipecolic acid pathway: the major lysine metabolic route in the rat brain. Biochem Biophys Res Commun (1976) 0.94
Excretion of pipecolic acid by infants and by patients with hyperlysinemia. Pediatr Res (1970) 0.94
A STUDY OF AMINO ACID OXIDASE SPECIFICITY, USING A NEW SENSITIVE ASSAY. Biochemistry (1964) 0.94
Spermidine/spermine-N1-acetyltransferase-2 (SSAT2) acetylates thialysine and is not involved in polyamine metabolism. Biochem J (2004) 0.93
The rat placenta and the transfer of thyroid hormones from the mother to the fetus. Effects of maternal thyroid status. Endocrinology (1992) 0.93
Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. FEBS Lett (1995) 0.92
Characterization of retinaldehyde dehydrogenase 3. Biochem J (2006) 0.92
Alpha-aminoadipate aminotransferase of rat liver mitochondria. Biochim Biophys Acta (1970) 0.92
Pyrroline-5-carboxylate reductase in human erythrocytes. J Clin Invest (1981) 0.92
Lysine-ketoglutarate reductase in human tissues. Biochim Biophys Acta (1975) 0.92
Effects of antidepressant treatment on gene expression profile in mouse brain: cell type-specific transcription profiling using laser microdissection and microarray analysis. J Neurochem (2006) 0.92
Reduced GABA synthesis in pyridoxine-dependent seizures. Lancet (1994) 0.91
The essential amino acid lysine acts as precursor of glutamate in the mammalian central nervous system. FEBS Lett (2001) 0.91
Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J Biol Chem (2000) 0.91
Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin Appl (2007) 0.91
The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res (1995) 0.91
Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci (2002) 1.92
Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones. J Neurochem (2011) 1.54
Plant phenylacetaldehyde synthase is a bifunctional homotetrameric enzyme that catalyzes phenylalanine decarboxylation and oxidation. J Biol Chem (2006) 1.48
Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapy. Crit Care Med (2011) 1.43
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med (2010) 1.27
Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics (2010) 1.19
Inhibitors of the alpha-ketoglutarate dehydrogenase complex alter [1-13C]glucose and [U-13C]glutamate metabolism in cerebellar granule neurons. J Neurosci Res (2006) 1.12
Phosphonate analogues of alpha-ketoglutarate inhibit the activity of the alpha-ketoglutarate dehydrogenase complex isolated from brain and in cultured cells. Biochemistry (2005) 1.08
Letter to the editor: μ-crystallin/CRYM functions as a ketimine-reducing enzyme and plays a role in thyroid hormone bioavailability due to strong inhibition/regulation by thyroid hormones. J Clin Endocrinol Metab (2015) 1.07
Novel protein modification by kynurenine in human lenses. J Biol Chem (2001) 1.05
Transglutaminases and neurodegeneration. J Neurochem (2009) 1.03
Testing hypotheses of aging in long-lived mice of the genus Peromyscus: association between longevity and mitochondrial stress resistance, ROS detoxification pathways, and DNA repair efficiency. Age (Dordr) (2008) 1.01
Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells. Cancer Prev Res (Phila) (2009) 1.01
Mechanism for the inhibition of transglutaminase 2 by cystamine. Biochem Pharmacol (2005) 0.98
Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria. Biochemistry (2005) 0.98
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease. J Neurochem (2005) 0.97
Protein-bound kynurenine is a photosensitizer of oxidative damage. Free Radic Biol Med (2004) 0.97
Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds. Amino Acids (2010) 0.96
Comparative kinetic analysis reveals that inducer-specific ion release precedes the mitochondrial permeability transition. Biochim Biophys Acta (2005) 0.96
Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells. Biochemistry (2006) 0.93
Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination. Biochimie (2009) 0.92
Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage. Free Radic Biol Med (2007) 0.92
UV filter instability: consequences for the human lens. Exp Eye Res (2002) 0.90
Increased levels of gamma-glutamylamines in Huntington disease CSF. J Neurochem (2008) 0.90
Inhibition of indoleamine 2,3 dioxygenase activity by H2O2. Arch Biochem Biophys (2006) 0.90
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels. J Bioenerg Biomembr (2010) 0.90
Glutathione and NADH, but not ascorbate, protect lens proteins from modification by UV filters. Exp Eye Res (2002) 0.89
Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.89
Urinary 2-hydroxy-5-oxoproline, the lactam form of α-ketoglutaramate, is markedly increased in urea cycle disorders. Anal Bioanal Chem (2011) 0.87
Enzyme-catalyzed side reactions with molecular oxygen may contribute to cell signaling and neurodegenerative diseases. Neurochem Res (2007) 0.87
Redox-sensitive proteins are potential targets of garlic-derived mercaptocysteine derivatives. J Nutr (2006) 0.86
The role of transglutaminases in neurodegenerative diseases: overview. Neurochem Int (2002) 0.86
Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem Res (2005) 0.86
Assay and purification of omega-amidase/Nit2, a ubiquitously expressed putative tumor suppressor, that catalyzes the deamidation of the alpha-keto acid analogues of glutamine and asparagine. Anal Biochem (2009) 0.86
Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1. J Pharmacol Exp Ther (2008) 0.85
Lenticular levels of amino acids and free UV filters differ significantly between normals and cataract patients. Invest Ophthalmol Vis Sci (2004) 0.85
The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane. Dalton Trans (2014) 0.84
A GC/MS-based metabolomic approach for diagnosing citrin deficiency. Anal Bioanal Chem (2011) 0.83
Transglutaminases - possible drug targets in human diseases. Curr Drug Targets CNS Neurol Disord (2004) 0.83
Reversible binding of kynurenine to lens proteins: potential protection by glutathione in young lenses. Invest Ophthalmol Vis Sci (2007) 0.81
Is protein methylation in the human lens a result of non-enzymatic methylation by S-adenosylmethionine? Exp Eye Res (2012) 0.81
Identification of the new UV filter compound cysteine-L-3-hydroxykynurenine O-beta-d-glucoside in human lenses. FEBS Lett (2006) 0.81
Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties. Amino Acids (2008) 0.81
Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen. Bioorg Med Chem (2011) 0.80
Spectrophotometric assays for L-lysine alpha-oxidase and gamma-glutamylamine cyclotransferase. Anal Biochem (2002) 0.79
Expression in Escherichia coli and purification of hexahistidine-tagged human tissue transglutaminase. Protein Expr Purif (2002) 0.79
Bactericidal and cyclooxygenase inhibitory diterpenes from Eremophila sturtii. Phytochemistry (2006) 0.79
Synthetic and natural polyanions induce cytochrome c release from mitochondria in vitro and in situ. Am J Physiol Cell Physiol (2011) 0.79
Structures of enzyme-intermediate complexes of yeast Nit2: insights into its catalytic mechanism and different substrate specificity compared with mammalian Nit2. Acta Crystallogr D Biol Crystallogr (2013) 0.78
Structural insights into the catalytic active site and activity of human Nit2/ω-amidase: kinetic assay and molecular dynamics simulation. J Biol Chem (2012) 0.78
From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D. Adv Nutr (2014) 0.78
Optimised expression and purification of recombinant human indoleamine 2,3-dioxygenase. Protein Expr Purif (2004) 0.77
Enzymatic analysis of α-ketoglutaramate--a biomarker for hyperammonemia. Talanta (2012) 0.77
Metabolism of cisplatin to a nephrotoxin. Toxicology (2008) 0.77
A survey of oxidative paracatalytic reactions catalyzed by enzymes that generate carbanionic intermediates: implications for ROS production, cancer etiology, and neurodegenerative diseases. Adv Enzymol Relat Areas Mol Biol (2011) 0.77
New mechanistic explanation for the localization of ulcers in the rat duodenum: role of iron and selective uptake of cysteamine. Arch Biochem Biophys (2012) 0.77
Separate mechanisms for age-related truncation and racemisation of peptide-bound serine. Amino Acids (2013) 0.77
A fluorescence-based assay for indoleamine 2,3-dioxygenase. Anal Biochem (2005) 0.77
New insights into the metabolism of organomercury compounds: mercury-containing cysteine S-conjugates are substrates of human glutamine transaminase K and potent inactivators of cystathionine γ-lyase. Arch Biochem Biophys (2011) 0.76
γ-Glutamylamines and neurodegenerative diseases. Amino Acids (2012) 0.76
Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions. Neurochem Res (2015) 0.76
A nonradioactive dot blot assay for transglutaminase activity. Anal Biochem (2009) 0.76
Stable isotope gas chromatography-tandem mass spectrometry determination of aminoethylcysteine ketimine decarboxylated dimer in biological samples. Anal Biochem (2012) 0.76
Mutation of cysteine residues alters the heme-binding pocket of indoleamine 2,3-dioxygenase-1. Biochem Biophys Res Commun (2013) 0.76
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1). Bioorg Med Chem (2013) 0.76
Inhibition of human glutamine synthetase by L-methionine-S,R-sulfoximine-relevance to the treatment of neurological diseases. Metab Brain Dis (2013) 0.75
Imine reductases: a comparison of glutamate dehydrogenase to ketimine reductases in the brain. Neurochem Res (2013) 0.75
Comment on absorption of aminoethyl cysteine ketimine decarboxylated dimer in mice: effect on plasma antioxidant potential. J Agric Food Chem (2013) 0.75
Food and Chemical Toxicology, 2011, 'Possible role of cysteine-S-conjugate β-lyase in species differences in cisplatin nephrotoxicity', R. Katayama, S. Nagata, H. Iida, N. Yamagishi, T. Yamashita, K. Furuhama. Food Chem Toxicol (2011) 0.75
Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity. Anal Bioanal Chem (2013) 0.75
Detection, quantification, and total synthesis of novel 3-hydroxykynurenine glucoside-derived metabolites present in human lenses. Invest Ophthalmol Vis Sci (2014) 0.75